Omnisalus Inc
Community/Retail Pharmacy
3110 New Bern Ave Ste 108, Raleigh
North Carolina, 27610-1200
919-703-0717 919-703-0861
Omnisalus Inc is a Community/Retail Pharmacy in Raleigh, North Carolina. It is located at 3110 New Bern Ave Ste 108, Raleigh and it's customer support contact number is 919-703-0717. The authorized person of Omnisalus Inc is Elvis Tanyi, PHARM.D, MBA who is Pharmacy Director of the pharmacy and his contact number is 919-757-8290. Active license number of Omnisalus Inc is 13181 for Community/Retail Pharmacy in North Carolina. Omnisalus Inc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Omnisalus Inc is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Omnisalus Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Omnisalus Inc |
| Type: | Community/Retail Pharmacy |
| Location: | 3110 New Bern Ave Ste 108, Raleigh,
North Carolina, 27610-1200 |
| Phone: | 919-703-0717 |
| Fax: | 919-703-0861 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Elvis Tanyi |
| Credentials: | PHARM.D, MBA |
| Position: | Pharmacy Director |
| Contact Number: | 919-757-8290 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1013468370 |
| NPI Enumeration Date: | 20 Oct, 2016 |
| NPI Last Update On: | 15 Feb, 2018 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Omnisalus Inc are as mentioned below.
| Specialization | License Number | State | Status | |
| Community/Retail Pharmacy | 13181 | North Carolina | Primary | |
| Pharmacist | 19478 | North Carolina | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 2167484 | Other | | Pk |
Medicare Enrollment:
Omnisalus Inc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 4183992977 | O20170620002092 | Omnisalus Inc | PART B SUPPLIER - MASS IMMUNIZATION (ROSTER BILLER ONLY) |
| 4183992977 | O20170710001758 | Omnisalus Inc | DME SUPPLIER - PHARMACY |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 3110 New Bern Ave Ste 108,
Raleigh, North Carolina |
| Zip: | 27610-1200 |
| Phone Number: | 919-703-0717 |
| Fax Number: | 919-703-0861 |
Patients can reach Omnisalus Inc at
3110 New Bern Ave Ste 108, Raleigh, North Carolina or can
call on customer care at 919-703-0717.
Comments/ Reviews:
Read all the reviews posted for Omnisalus Inc below. You may also share your own experience with Omnisalus Inc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.